$TCDA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Tricida, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Tricida, Inc.. Get notifications about new insider transactions in Tricida, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 27 2021 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 4.56 | 5,000 | 22,800 | 147,509 | 152.5 K to 147.5 K (-3.28 %) |
Apr 21 2021 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 4.54 | 5,000 | 22,700 | 152,509 | 157.5 K to 152.5 K (-3.17 %) |
Mar 12 2021 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 4.79 | 5,000 | 23,950 | 157,509 | 162.5 K to 157.5 K (-3.08 %) |
Feb 09 2021 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 7.26 | 8,000 | 58,080 | 499,993 | 508 K to 500 K (-1.57 %) |
Feb 04 2021 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 6.91 | 5,000 | 34,550 | 162,609 | 167.6 K to 162.6 K (-2.98 %) |
Jan 27 2021 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 7.06 | 5,000 | 35,300 | 167,609 | 172.6 K to 167.6 K (-2.90 %) |
Jan 20 2021 | TCDA | Tricida, Inc. | Yoshiyama Annie | VP, Finance and CAO | Option Exercise | A | 7.03 | 70,980 | 498,989 | 70,980 | |
Jan 20 2021 | TCDA | Tricida, Inc. | Stahl Wilhelm | EVP, Chief Tech Off ... | Option Exercise | A | 7.03 | 78,000 | 548,340 | 78,000 | |
Jan 20 2021 | TCDA | Tricida, Inc. | McKague Robert | EVP, General Counse ... | Option Exercise | A | 7.03 | 157,500 | 1,107,225 | 157,500 | |
Jan 20 2021 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | A | 7.03 | 186,000 | 1,307,580 | 186,000 | |
Jan 20 2021 | TCDA | Tricida, Inc. | Parker Geoffrey M. | CFO and EVP | Option Exercise | A | 7.03 | 216,000 | 1,518,480 | 216,000 | |
Jan 20 2021 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Option Exercise | A | 7.03 | 271,748 | 1,910,388 | 271,748 | |
Jan 15 2021 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 7.18 | 1,655 | 11,883 | 507,993 | 509.6 K to 508 K (-0.32 %) |
Jan 15 2021 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 7.41 | 15,035 | 111,409 | 509,648 | 524.7 K to 509.6 K (-2.87 %) |
Jan 13 2021 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 7.65 | 9,821 | 75,131 | 524,683 | 534.5 K to 524.7 K (-1.84 %) |
Jan 12 2021 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 7.49 | 21,489 | 160,953 | 534,504 | 556 K to 534.5 K (-3.86 %) |
Dec 23 2020 | TCDA | Tricida, Inc. | McKague Robert | EVP, General Counse ... | Buy | P | 7.62 | 10,000 | 76,200 | 10,000 | 0 to 10 K |
Dec 15 2020 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 7.90 | 50,000 | 395,000 | 172,609 | 222.6 K to 172.6 K (-22.46 %) |
Dec 10 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | CFO and EVP | Buy | P | 6.78 | 15,000 | 101,700 | 40,000 | 25 K to 40 K (+60.00 %) |
Dec 08 2020 | TCDA | Tricida, Inc. | Yoshiyama Annie | VP, Finance and CAO | Option Exercise | A | 7.66 | 20,000 | 153,200 | 20,000 | |
Sep 14 2020 | TCDA | Tricida, Inc. | Cobo Marc | SVP, Finance & CAO | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Sep 14 2020 | TCDA | Tricida, Inc. | Stahl Wilhelm | EVP, Chief Tech Off ... | Grant | A | 0.00 | 4,000 | 0 | 19,478 | 15.5 K to 19.5 K (+25.84 %) |
Sep 14 2020 | TCDA | Tricida, Inc. | Cantrell Susannah | EVP, Chief Comm. Of ... | Grant | A | 0.00 | 4,000 | 0 | 4,000 | 0 to 4 K |
Sep 14 2020 | TCDA | Tricida, Inc. | McKague Robert | EVP, General Counse ... | Grant | A | 0.00 | 4,000 | 0 | 4,000 | 0 to 4 K |
Sep 14 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Grant | A | 0.00 | 4,000 | 0 | 60,837 | 56.8 K to 60.8 K (+7.04 %) |
Sep 14 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Grant | A | 0.00 | 8,000 | 0 | 555,993 | 548 K to 556 K (+1.46 %) |
Sep 14 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Grant | A | 0.00 | 4,000 | 0 | 4,637 | 637 to 4.6 K (+627.94 %) |
Sep 14 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Grant | A | 0.00 | 4,000 | 0 | 4,637 | 637 to 4.6 K (+627.94 %) |
Jul 16 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 26.33 | 4,000 | 105,320 | 25,323 | 29.3 K to 25.3 K (-13.64 %) |
Jul 02 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 27.15 | 4,000 | 108,600 | 547,321 | 551.3 K to 547.3 K (-0.73 %) |
Jul 01 2020 | TCDA | Tricida, Inc. | Cobo Marc | SVP, Finance & CAO | Option Exercise | A | 25.55 | 80,000 | 2,044,000 | 80,000 | |
Jun 16 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 26.20 | 2,100 | 55,020 | 29,323 | 31.4 K to 29.3 K (-6.68 %) |
Jun 16 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 25.71 | 1,900 | 48,849 | 31,423 | 33.3 K to 31.4 K (-5.70 %) |
Jun 15 2020 | TCDA | Tricida, Inc. | Bonita David P | Director | Option Exercise | A | 25.40 | 22,967 | 583,362 | 22,967 | |
Jun 15 2020 | TCDA | Tricida, Inc. | Bonita David P | Director | Grant | A | 0.00 | 5,670 | 0 | 11,181 | 5.5 K to 11.2 K (+102.89 %) |
Jun 15 2020 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Option Exercise | A | 25.40 | 22,967 | 583,362 | 22,967 | |
Jun 15 2020 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Grant | A | 0.00 | 5,670 | 0 | 222,609 | 216.9 K to 222.6 K (+2.61 %) |
Jun 15 2020 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Option Exercise | A | 25.40 | 22,967 | 583,362 | 22,967 | |
Jun 15 2020 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Grant | A | 0.00 | 5,670 | 0 | 46,985 | 41.3 K to 47 K (+13.72 %) |
Jun 15 2020 | TCDA | Tricida, Inc. | FALBERG KATHRYN E | Director | Option Exercise | A | 25.40 | 22,967 | 583,362 | 22,967 | |
Jun 15 2020 | TCDA | Tricida, Inc. | FALBERG KATHRYN E | Director | Grant | A | 0.00 | 5,670 | 0 | 42,760 | 37.1 K to 42.8 K (+15.29 %) |
Jun 15 2020 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Option Exercise | A | 25.40 | 22,967 | 583,362 | 22,967 | |
Jun 15 2020 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 5,670 | 0 | 143,060 | 137.4 K to 143.1 K (+4.13 %) |
Jun 15 2020 | TCDA | Tricida, Inc. | Hirsch David | Director | Option Exercise | A | 25.40 | 22,967 | 583,362 | 22,967 | |
Jun 15 2020 | TCDA | Tricida, Inc. | Hirsch David | Director | Option Exercise | A | 25.40 | 22,967 | 583,362 | 22,967 | |
Jun 15 2020 | TCDA | Tricida, Inc. | Hirsch David | Director | Grant | A | 0.00 | 5,670 | 0 | 11,181 | 5.5 K to 11.2 K (+102.89 %) |
Jun 15 2020 | TCDA | Tricida, Inc. | Hirsch David | Director | Grant | A | 0.00 | 5,670 | 0 | 11,181 | 5.5 K to 11.2 K (+102.89 %) |
Jun 03 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 26.23 | 4,000 | 104,920 | 551,321 | 555.3 K to 551.3 K (-0.72 %) |
May 19 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 31.87 | 2,000 | 63,740 | 33,323 | 35.3 K to 33.3 K (-5.66 %) |
May 19 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 31.24 | 2,000 | 62,480 | 35,323 | 37.3 K to 35.3 K (-5.36 %) |
May 12 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 31.66 | 1,439 | 45,559 | 95,000 | 93.6 K to 95 K (+1.54 %) |
May 12 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 30.09 | 1,303 | 39,207 | 93,561 | 92.3 K to 93.6 K (+1.41 %) |
May 12 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 30.36 | 19,854 | 602,767 | 92,258 | 72.4 K to 92.3 K (+27.42 %) |
May 12 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 29.48 | 12,404 | 365,670 | 72,404 | 60 K to 72.4 K (+20.67 %) |
May 12 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 2.39 | 1,437 | 3,434 | 15,386 | |
May 12 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 7.49 | 523 | 3,917 | 23,033 | |
May 12 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 1.68 | 830 | 1,394 | 4,190 | |
May 12 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 1.68 | 210 | 353 | 420 | |
May 12 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 1,437 | 45,955 | 255 | 1.7 K to 255 (-84.93 %) |
May 12 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 2.39 | 1,437 | 3,434 | 1,692 | 255 to 1.7 K (+563.53 %) |
May 12 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 523 | 16,726 | 255 | 778 to 255 (-67.22 %) |
May 12 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 7.49 | 523 | 3,917 | 778 | 255 to 778 (+205.10 %) |
May 12 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 830 | 26,543 | 255 | 1.1 K to 255 (-76.50 %) |
May 12 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 1.68 | 830 | 1,394 | 1,085 | 255 to 1.1 K (+325.49 %) |
May 12 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 210 | 6,716 | 255 | 465 to 255 (-45.16 %) |
May 12 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 1.68 | 210 | 353 | 465 | 255 to 465 (+82.35 %) |
May 07 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 2.39 | 452 | 1,080 | 16,823 | |
May 07 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 1.68 | 798 | 1,341 | 5,020 | |
May 07 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 30.31 | 452 | 13,700 | 255 | 707 to 255 (-63.93 %) |
May 07 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 2.39 | 452 | 1,080 | 707 | 255 to 707 (+177.25 %) |
May 07 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 30.05 | 798 | 23,980 | 255 | 1.1 K to 255 (-75.78 %) |
May 07 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 1.68 | 798 | 1,341 | 1,053 | 255 to 1.1 K (+312.94 %) |
May 04 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 29.51 | 100 | 2,951 | 555,321 | 555.4 K to 555.3 K (-0.02 %) |
May 04 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 28.86 | 850 | 24,531 | 555,421 | 556.3 K to 555.4 K (-0.15 %) |
May 04 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 27.68 | 3,050 | 84,424 | 556,271 | 559.3 K to 556.3 K (-0.55 %) |
Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 7.49 | 523 | 3,917 | 23,556 | |
Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 2.39 | 523 | 1,250 | 17,275 | |
Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 1.68 | 1,744 | 2,930 | 5,818 | |
Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 1.68 | 210 | 353 | 630 | |
Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 1.68 | 1,250 | 2,100 | 7,562 | |
Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 523 | 16,726 | 255 | 778 to 255 (-67.22 %) |
Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 7.49 | 523 | 3,917 | 778 | 255 to 778 (+205.10 %) |
Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 523 | 16,726 | 255 | 778 to 255 (-67.22 %) |
Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 2.39 | 523 | 1,250 | 778 | 255 to 778 (+205.10 %) |
Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 1,744 | 55,773 | 255 | 2 K to 255 (-87.24 %) |
Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 1.68 | 1,744 | 2,930 | 1,999 | 255 to 2 K (+683.92 %) |
Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 210 | 6,716 | 255 | 465 to 255 (-45.16 %) |
Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 1.68 | 210 | 353 | 465 | 255 to 465 (+82.35 %) |
Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 29.98 | 1,250 | 37,475 | 255 | 1.5 K to 255 (-83.06 %) |
Apr 30 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 1.68 | 1,250 | 2,100 | 1,505 | 255 to 1.5 K (+490.20 %) |
Apr 16 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 27.97 | 100 | 2,797 | 37,323 | 37.4 K to 37.3 K (-0.27 %) |
Apr 16 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 27.46 | 3,900 | 107,094 | 37,423 | 41.3 K to 37.4 K (-9.44 %) |
Apr 16 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 27.97 | 100 | 2,797 | 37,323 | 37.4 K to 37.3 K (-0.27 %) |
Apr 16 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 27.46 | 3,900 | 107,094 | 37,423 | 41.3 K to 37.4 K (-9.44 %) |
Apr 08 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 24.22 | 4,000 | 96,880 | 559,321 | 563.3 K to 559.3 K (-0.71 %) |
Mar 18 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 23.91 | 4,000 | 95,640 | 41,323 | 45.3 K to 41.3 K (-8.83 %) |
Mar 11 2020 | TCDA | Tricida, Inc. | McKague Robert | EVP, General Counse ... | Option Exercise | A | 31.14 | 210,000 | 6,539,400 | 210,000 | |
Mar 11 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Buy | P | 29.46 | 5,000 | 147,300 | 55,000 | 50 K to 55 K (+10.00 %) |
Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 7.49 | 523 | 3,917 | 24,079 | |
Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 2.39 | 523 | 1,250 | 17,798 | |
Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 1.68 | 2,994 | 5,030 | 8,812 | |
Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Option Exercise | M | 1.68 | 210 | 353 | 840 | |
Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 523 | 16,726 | 255 | 778 to 255 (-67.22 %) |
Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 7.49 | 523 | 3,917 | 778 | 255 to 778 (+205.10 %) |
Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 523 | 16,726 | 255 | 778 to 255 (-67.22 %) |
Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 2.39 | 523 | 1,250 | 778 | 255 to 778 (+205.10 %) |
Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.78 | 2,994 | 95,149 | 255 | 3.2 K to 255 (-92.15 %) |
Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 1.68 | 2,994 | 5,030 | 3,249 | 255 to 3.2 K (+1,174.12 %) |
Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Sell | S | 31.98 | 210 | 6,716 | 255 | 465 to 255 (-45.16 %) |
Mar 04 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | EVP, Clinical Devel ... | Buy | M | 1.68 | 210 | 353 | 465 | 255 to 465 (+82.35 %) |
Mar 04 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | EVP, General Counse ... | Option Exercise | M | 0.96 | 10,000 | 9,600 | 104,143 | |
Mar 04 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | EVP, General Counse ... | Sell | S | 32.23 | 200 | 6,446 | 19,153 | 19.4 K to 19.2 K (-1.03 %) |
Mar 04 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | EVP, General Counse ... | Buy | M | 0.96 | 200 | 192 | 19,353 | 19.2 K to 19.4 K (+1.04 %) |
Mar 04 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | EVP, General Counse ... | Sell | S | 31.65 | 9,800 | 310,170 | 19,153 | 29 K to 19.2 K (-33.85 %) |
Mar 04 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | EVP, General Counse ... | Buy | M | 0.96 | 9,800 | 9,408 | 28,953 | 19.2 K to 29 K (+51.17 %) |
Mar 04 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 31.53 | 4,000 | 126,120 | 563,321 | 567.3 K to 563.3 K (-0.71 %) |
Feb 26 2020 | TCDA | Tricida, Inc. | Pietzke Steffen | VP Fin & Chief Acct ... | Option Exercise | A | 35.12 | 60,000 | 2,107,200 | 60,000 | |
Feb 26 2020 | TCDA | Tricida, Inc. | Parker Geoffrey M. | Chief Fin. Officer ... | Option Exercise | A | 35.12 | 130,000 | 4,565,600 | 130,000 | |
Feb 26 2020 | TCDA | Tricida, Inc. | Cantrell Susannah | Sr. VP, Chief Comm. ... | Option Exercise | A | 35.12 | 100,000 | 3,512,000 | 100,000 | |
Feb 26 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | A | 35.12 | 130,000 | 4,565,600 | 130,000 | |
Feb 26 2020 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Option Exercise | A | 35.12 | 40,000 | 1,404,800 | 40,000 | |
Feb 26 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Option Exercise | A | 35.12 | 292,000 | 10,255,040 | 292,000 | |
Feb 20 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 36.10 | 4,000 | 144,400 | 45,323 | 49.3 K to 45.3 K (-8.11 %) |
Feb 06 2020 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Option Exercise | M | 1.68 | 500 | 840 | 199,942 | |
Feb 06 2020 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Sell | S | 38.91 | 500 | 19,455 | 14,806 | 15.3 K to 14.8 K (-3.27 %) |
Feb 06 2020 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Buy | M | 1.68 | 500 | 840 | 15,306 | 14.8 K to 15.3 K (+3.38 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 7.49 | 523 | 3,917 | 24,602 | |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 2.39 | 523 | 1,250 | 18,321 | |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 1.68 | 2,994 | 5,030 | 11,806 | |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 1.68 | 210 | 353 | 1,050 | |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 37.62 | 523 | 19,675 | 255 | 778 to 255 (-67.22 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 7.49 | 523 | 3,917 | 778 | 255 to 778 (+205.10 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 37.31 | 523 | 19,513 | 255 | 778 to 255 (-67.22 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 2.39 | 523 | 1,250 | 778 | 255 to 778 (+205.10 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 37.51 | 400 | 15,004 | 255 | 655 to 255 (-61.07 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 36.74 | 2,336 | 85,825 | 655 | 3 K to 655 (-78.10 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 35.58 | 258 | 9,180 | 2,991 | 3.2 K to 3 K (-7.94 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 1.68 | 2,994 | 5,030 | 3,249 | 255 to 3.2 K (+1,174.12 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 35.58 | 210 | 7,472 | 255 | 465 to 255 (-45.16 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 1.68 | 210 | 353 | 465 | 255 to 465 (+82.35 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | SVP, General Counse ... | Option Exercise | M | 0.96 | 10,000 | 9,600 | 114,143 | |
Feb 05 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | SVP, General Counse ... | Sell | S | 36.63 | 7,869 | 288,241 | 19,153 | 27 K to 19.2 K (-29.12 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | SVP, General Counse ... | Buy | M | 0.96 | 7,869 | 7,554 | 27,022 | 19.2 K to 27 K (+41.08 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | SVP, General Counse ... | Sell | S | 35.63 | 2,131 | 75,928 | 19,153 | 21.3 K to 19.2 K (-10.01 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | HEJLEK EDWARD J | SVP, General Counse ... | Buy | M | 0.96 | 2,131 | 2,046 | 21,284 | 19.2 K to 21.3 K (+11.13 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 36.58 | 2,900 | 106,082 | 567,321 | 570.2 K to 567.3 K (-0.51 %) |
Feb 05 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 35.68 | 1,100 | 39,248 | 570,221 | 571.3 K to 570.2 K (-0.19 %) |
Jan 16 2020 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 35.26 | 4,000 | 141,040 | 49,323 | 53.3 K to 49.3 K (-7.50 %) |
Jan 06 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 1.68 | 2,365 | 3,973 | 16,060 | |
Jan 06 2020 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 1.68 | 1,885 | 3,167 | 0 |